09.10.2020 • Product

Optimal Time-to-Market for Life-Saving Biopharmaceuticals

Rentschler provides the best solution to guarantee the success of its client’s project and meet clinical and commercial needs.

The company leverages its established know-how to evaluate the best production approach for its client’s molecule and offers tailor-made timelines for therapeutics. By accelerating timelines via economically attractive process options, it generates competitive advantages for its client’s product, without compromising quality or safety.

Rentschler’s best-in-class project management team ensures that needs are reflected in every detail of project design, planning and execution from the beginning. It couples this collaborative approach with its deep knowledge of regulatory affairs. This results in an unrivalled track record in successful audits and approvals from health authorities around the globe.

Rentschler’s website offers additional information about the company’s accelerated timelines, considering economically attractive process options.

Company

Logo:

Rentschler Biopharma SE

Erwin-Rentschler-Str. 21
88471 Laupheim
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read